Trial Profile
A Phase I Study to Assess the Safety, Tolerability and Pharmacokinetics of NOV120401 (CKD-516 Tablet) in Patients With Advanced Refractory Solid Tumors
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Valecobulin (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 13 Aug 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
- 28 Nov 2014 New trial record